Drug Shortage Report for SODIUM CHLORIDE 3% INJ
Report ID | 197763 |
Drug Identification Number | 00060232 |
Brand name | SODIUM CHLORIDE 3% INJ |
Common or Proper name | SODIUM CHLORIDE 3% INJ |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 3G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 250 mL - JB1352 |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-07-06 |
Actual start date | 2023-07-06 |
Estimated end date | 2023-08-14 |
Actual end date | 2023-08-14 |
Shortage status | Resolved |
Updated date | 2023-08-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-07-06 | English | Compare |
v2 | 2023-07-06 | French | Compare |
v3 | 2023-07-07 | English | Compare |
v4 | 2023-08-01 | English | Compare |
v5 | 2023-08-01 | French | Compare |
v6 | 2023-08-14 | English | Compare |
v7 | 2023-08-14 | French | Compare |
v8 | 2023-08-15 | English | Compare |
Showing 1 to 8 of 8